References
- Bruyn GA. Controversies in lupus: nervous system involvement. Ann Rheum Dis. 1995;54:159–167.
- Futrell N, Schultz LR, Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology. 1992;42:1649–1657.
- Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology. 2007;69:644–654.
- Sibley JT, Olszynski WP, Decoteau WE, et al. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol. 1992;19:47–52.
- Wong KL, Woo EK, Yu YL, et al. Neurological manifestations of systemic lupus erythematosus: a prospective study. Q J Med. 1991;81:857–870.
- Liang MH, Corzillius M, Bae S, et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.
- Swaak AJ, Nossent JC, Bronsveld W, et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis. 1989;48:447–454.
- Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42(2):338–346.
- Bertsias GK, Boumpas DT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol. 2010;6:358–367.
- Watanabe R, Fujii H, Shirai T, et al. Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus. Intern Med. 2014;53:627–631.
- Cohen D, Rijnink EC, Nabuurs RJ, et al. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement. Rheumatol. 2017;56(1):77–86.
- Pizzolato GP, Sztajzel R, Burkhardt K, et al. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. Neurology. 1998;50(4):1154–1157.
- Mahler C, Unterrainer M, Muth C, et al. Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET. Neurology. 2018;91(20):936–937.
- Ringelstein A, Bongs K, Sorge-Hädicke B, et al. [Case of inflammatory vasculopathy and encephalopathy caused by treatment with tacrolimus]. Nervenarzt. 2005;76(4):475–478.
- Outteryck O, Sénéchal O, Berteloot D, et al. Rev Neurol (Paris). 2005;161(8–9):836–839.
- Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005;64(4):620–625.